MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1 |
Lee, Kyoung-Hwa
(Department of Urology, Seoul National University Hospital)
Kim, Byung-Chan (Department of Urology, Seoul National University Hospital) Jeong, Chang Wook (Department of Urology, Seoul National University Hospital) Ku, Ja Hyeon (Department of Urology, Seoul National University Hospital) Kim, Hyeon Hoe (Department of Urology, Seoul National University Hospital) Kwak, Cheol (Department of Urology, Seoul National University Hospital) |
1 | Wysocka J, Myers MP, Laherty CD, Eisenman RN and Herr W (2003) Human Sin3 deacetylase and trithoraxrelated Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev 17, 896-911 DOI |
2 | Mora GR and Mahesh VB (1999) Autoregulation of the androgen receptor at the translational level: Testosterone induces accumulation of androgen receptor mrna in the rat ventral prostate polyribosomes. Steroids 64, 587-591 DOI |
3 | Coutinho I, Day TK, Tilley WD and Selth LA (2016) Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer 23, T179-T197 DOI |
4 | Lu S, Tsai SY and Tsai MJ (1997) Regulation of androgendependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res 57, 4511-4516 |
5 | Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang Q-XA and Li B (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144, 1656-1663 DOI |
6 | Kim EY, Jin BR, Chung TW et al (2019) 6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis. BMB Rep 52, 560-565 DOI |
7 | Linder S, van der Poel HG, Bergman AM, Zwart W and Prekovic S (2018) Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond. Endocr Relat Cancer 26, R31-R52 DOI |
8 | Altintas DM, Rouault JP, Samarut J et al (2012) Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells. Mol Endocrinol 26, 1531-1541 DOI |
9 | Sharma A, Yeow W-S, Ertel A et al (2010) The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120, 4478-4492 DOI |
10 | Narayanan A, Ruyechan WT and Kristie TM (2007) The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proc Natl Acad Sci U S A 104, 10835-10840 DOI |
11 | Peterson CL and Laniel MA (2004) Histones and histone modifications. Curr Biol 14, R546-551 DOI |
12 | Schrecengost R and Knudsen KE (2013) Molecular pathogenesis and progression of prostate cancer. Semin Oncol 40, 244-258 DOI |
13 | Siegel RL, Miller KD and Jemal A (2019) Cancer statistics, 2019. CA: A Cancer Journal for Clinicians 69, 7-34 DOI |
14 | Masson S and Bahl A (2012) Metastatic castrate-resistant prostate cancer: dawn of a new age of management. BJU Int 110, 1110-1114 DOI |
15 | Claessens F, Helsen C, Prekovic S et al (2014) Emerging mechanisms of enzalutamide resistance in prostate cancer. Nat Rev Urol 11, 712-716 DOI |
16 | Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG and Evans CP (2017) Epigenomic regulation of androgen receptor signaling: potential role in prostate cancer therapy. Cancers 9, 9 DOI |
17 | Gaughan L, Stockley J, Wang N et al (2011) Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res 39, 1266-1279 DOI |
18 | Kang HB, Choi Y, Lee JM et al (2009) The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription. FEBS Lett 583, 1880-1886 DOI |
19 | Cai C, He HH, Chen S et al (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 20, 457-471 DOI |
20 | Varambally S, Dhanasekaran SM, Zhou M et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629 DOI |
21 | Metzger E, Wissmann M, Yin N et al (2005) LSD1 demethylates repressive histone marks to promote androgenreceptor-dependent transcription. Nature 437, 436-439 DOI |
22 | Zhou P, Ding X, Wan X et al (2018) MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation. Nat Commun 9, 1243 DOI |
23 | Kang MK, Mehrazarin S, Park NH and Wang CY (2017) Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation. Oral Dis 23, 709-720 DOI |
24 | Willmann D, Lim S, Wetzel S et al (2012) Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor. Int J Cancer 131, 2704-2709 DOI |
25 | Lee KH, Hong S, Kang M et al (2018) Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer. Int J Cancer 143, 2849-2861 DOI |
26 | Deng LW, Chiu I and Strominger JL (2004) MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Natl Acad Sci U S A 101, 757-762 DOI |
27 | Mas YMS, Barbon M, Teyssier C et al (2016) The human mixed lineage leukemia 5 (MLL5), a sequentially and structurally divergent SET domain-containing protein with no intrinsic catalytic activity. PLoS One 11, e0165139 DOI |
28 | Ali M, Rincon-Arano H, Zhao W et al (2013) Molecular basis for chromatin binding and regulation of MLL5. Proc Natl Acad Sci U S A 110, 11296-11301 DOI |
29 | Zhang Y, Wong J, Klinger M, Tran MT, Shannon KM and Killeen N (2009) MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood 113, 1455-1463 DOI |
30 | Yap DB, Walker DC, Prentice LM et al (2011) Mll5 is required for normal spermatogenesis. PLoS One 6, e27127 DOI |
31 | Zhou P, Wang Z, Yuan X et al (2013) Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1). J Biol Chem 288, 17532-17543 DOI |